National supported research with China
In 2013 the Swedish Research Council (Vetenskapsrådet) launched two calls for research collaborations with China.
The Karolinska-China-Hong Kong Regenerative Medicine Initiative
KI researcher Ken Chien was awarded one of the four, highly competitive, grants for The Karolinska-China-Hong Kong Regenerative Medicine Initiative. The grant is 4 800 000 per year for five years.
Framework grant in antimicrobial resistance, Sweden-NSFC (China) joint research program
The second call was funded jointly by the Swedish Research Council and the Natural Science Foundation, China and was called "Framework grant in antimicrobial resistance, Sweden-NSFC (China) joint research program”.
KI was awarded two of these grants (5 000 000 a year for five years):
- Novel natural compounds that target the cell wall (and other components) of bacteria: generation of basic knowledge, new tools and potential drugs candidates, Birgitta Henriques Normark.
Read more about Birgitta Henriques Normark's research group.
- Epidemiology, risk factors and transmission mechanisms of the emergence of multidrug and extensively drug resistant tuberculosis, Sven Hoffner.
Read more about Sven Hoffner's research group.
Public Health Agency of Sweden
In addition to the two above mentioned grants, KI researchers are involved in a a project from the Public Health Agency of Sweden that was awarded a grant:
- IMPACT - Svensk-Kinesiskt tvärsektoriellt samarbete för begränsning av antibiotikaresistens (Swedish-Chinese cross-sectoral cooperation for limiting antibiotic resistance), PI Otto Cars, Uppsala university, and KI-collaborators Göran Tomson/Cecilia Stålsby-Lundborg.